Treace Medical Concepts, Inc. (NASDAQ: TMCI) is a medical device company focused on surgical solutions for bunion correction and related forefoot deformities. The company generates revenue through the sale of its proprietary implant systems and instrumentation to hospitals and ambulatory surgical centers, where surgeons use the products during orthopedic foot procedures. The 10-K filed 2026-02-27 (accession 0001193125-26-07-9167) does not provide sufficient excerpt detail to specify exact revenue figures, segment breakdowns, geographic mix, named competitors, customer concentration, or founding and leadership history within the provided filing excerpts. Based solely on the excerpts available, the company is structured as a single-product-category medical device business selling transactionally into the surgical setting, with revenue tied directly to procedure volume.

Revenue model

Transactional sale of surgical implant systems and instrumentation to hospitals and ambulatory surgical centers. Revenue is procedure-volume dependent. Specific figures are not supported by the provided filing excerpts.

Products and services

Proprietary surgical implant systems and instrumentation for bunion correction and forefoot deformity procedures. Specific product names are not supported by the provided filing excerpts.

Customers and end markets

Hospitals and ambulatory surgical centers performing orthopedic foot surgery. End market is elective and reconstructive foot surgery. Specific customer concentration data is not supported by the provided filing excerpts.

Value-chain role

Medical device manufacturer and direct seller of surgical implants and instrumentation into the orthopedic foot surgery setting.

Geographic exposure

Not supported by the provided filing excerpts.

Source: SEC 10-K, filed 2026-02-27

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories AtriCure Inc Cryoport Inc LeMaitre Vascular Inc NEVRO CORP Paragon 28, Inc. Procept Biorobotics Corp Transmedics Group Inc